BackAlexion Pharmaceuticals Overview

Alexion Pharmaceuticals Total Revenue

Revenue analysis for ALXN.

Quarterly Revenue

$1.64B
13.27% YoY

As of Mar 2021

Annual Revenue (TTM)

$6.26B
18.24% YoY

Trailing 12 months ending Mar 2021

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading